264 related articles for article (PubMed ID: 28539567)
1. SYNTAX Score-II Predicts Long-Term Mortality in Patients Who Underwent Left Main Percutaneous Coronary Intervention Treated With Second-Generation Drug-Eluting Stents.
He J; Zhao H; Yu X; Li Q; Lv S; Chen F; Jiang T
Int Heart J; 2017 May; 58(3):344-350. PubMed ID: 28539567
[TBL] [Abstract][Full Text] [Related]
2. Predictive Ability of the SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery Score II for Long-term Mortality in Patients with Three-vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Treated with Second-generation Drug-eluting Stents.
He JQ; Yu XP; Peng C; Li Q; Luo YW; Gao YC; Zhang XL; Wu CY; Zhao H; Zhang YC; Liu JH; Lyu SZ; Chen F
Chin Med J (Engl); 2015 Aug; 128(16):2176-82. PubMed ID: 26265610
[TBL] [Abstract][Full Text] [Related]
3. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials.
Xhepa E; Tada T; Kufner S; Ndrepepa G; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Cassese S; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A
Catheter Cardiovasc Interv; 2017 Jan; 89(1):1-10. PubMed ID: 27515100
[TBL] [Abstract][Full Text] [Related]
5. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
6. Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study).
Cerrato E; Barbero U; Quadri G; Ryan N; D'Ascenzo F; Tomassini F; Quirós A; Bellucca S; Conrotto F; Ugo F; Kawamoto H; Rolfo C; Pavani M; Mejia-Renteria H; Gili S; Iannaccone M; Debenedictis M; Baldassarre D; Biondi-Zoccai G; Colombo A; Varbella F; Escaned J
Catheter Cardiovasc Interv; 2020 Jul; 96(1):E17-E26. PubMed ID: 31478334
[TBL] [Abstract][Full Text] [Related]
7. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention.
Wang G; Wang C; Zhang Y; Wang P; Ran C; Zhao L; Han L
Coron Artery Dis; 2016 Sep; 27(6):483-9. PubMed ID: 27171362
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial.
Lee J; Ahn JM; Kim JH; Jeong YJ; Hyun J; Yang Y; Lee JS; Park H; Kang DY; Lee PH; Park DW; Park SJ;
J Am Heart Assoc; 2021 Jul; 10(14):e020359. PubMed ID: 34227392
[TBL] [Abstract][Full Text] [Related]
10. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
[TBL] [Abstract][Full Text] [Related]
11. Impact of the clinical syntax score on 5-year clinical outcomes after sirolimus-eluting stents implantation.
Hara H; Aoki J; Tanabe K; Nishi A; Tanimoto S; Nakajima Y; Yahagi K; Nakashima M; Hashimoto T; Asami M; Watanabe M; Yoshida E; Nakajima H; Hara K
Cardiovasc Interv Ther; 2013 Jul; 28(3):258-66. PubMed ID: 23392971
[TBL] [Abstract][Full Text] [Related]
12. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
Garg S; Serruys PW; Silber S; Wykrzykowska J; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; DiMario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli A; Van Remortel E; Ronden J; Windecker S
JACC Cardiovasc Interv; 2011 Apr; 4(4):432-41. PubMed ID: 21511223
[TBL] [Abstract][Full Text] [Related]
13. Identify Unsuitable Patients with Left Main Coronary Artery Disease in Intermediate SYNTAX Scores Treated by Percutaneous Coronary Intervention.
Zhang C; Zheng Y; Liu X; Cheng Y; Liu Y; Yao Y; Wang X; Xu J
Heart Surg Forum; 2017 Dec; 20(6):E258-E262. PubMed ID: 29272225
[TBL] [Abstract][Full Text] [Related]
14. Validation of the long-term prognostic capability of the SYNTAX score II in patients undergoing biodegradable polymer-based Sirolimus-eluting stents: 2-year outcomes from the PANDA III trial.
Song Y; Guan C; Cao X; Qin L; Li Y; Li Z; Nie S; Hou S; Zhang M; Gao R; Yuan J; Xu B;
Int J Cardiol; 2020 Jun; 309():27-32. PubMed ID: 32238273
[TBL] [Abstract][Full Text] [Related]
15. Syntax score predicts clinical outcome in patients with three-vessel coronary artery disease undergoing percutaneous coronary intervention.
He JQ; Gao YC; Yu XP; Zhang XL; Luo YW; Wu CY; Li Y; Zhang WD; Chen F; Lü SZ
Chin Med J (Engl); 2011 Mar; 124(5):704-9. PubMed ID: 21518562
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
[TBL] [Abstract][Full Text] [Related]
17. Predictive Value of Combining the Ankle-Brachial Index and SYNTAX Score for the Prediction of Outcome After Percutaneous Coronary Intervention (from the SHINANO Registry).
Ueki Y; Miura T; Miyashita Y; Motoki H; Shimada K; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Aso S; Uchikawa S; Hashizume N; Sekimura N; Morita T; Ebisawa S; Izawa A; Koyama J; Ikeda U
Am J Cardiol; 2016 Jan; 117(2):179-85. PubMed ID: 26684515
[TBL] [Abstract][Full Text] [Related]
18. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.
Girasis C; Garg S; Räber L; Sarno G; Morel MA; Garcia-Garcia HM; Lüscher TF; Serruys PW; Windecker S
Eur Heart J; 2011 Dec; 32(24):3115-27. PubMed ID: 21951630
[TBL] [Abstract][Full Text] [Related]
19. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
[TBL] [Abstract][Full Text] [Related]
20. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
